• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlation of histomorphologic prognostic markers and proliferative index with loss of heterozygosity 1p/19q and MGMT status in diffusely infiltrating gliomas.弥漫性浸润性胶质瘤中组织形态学预后标志物及增殖指数与1p/19q杂合性缺失和MGMT状态的相关性
Med J Armed Forces India. 2013 Jul;69(3):228-36. doi: 10.1016/j.mjafi.2012.08.030. Epub 2012 Dec 1.
2
Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.世界卫生组织(WHO)II级和III级弥漫性胶质瘤中1号染色体短臂(1p)和19号染色体长臂(19q)状态与O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)、p53和Ki-67表达的相关性:一项临床病理研究
Neuropathol Appl Neurobiol. 2009 Aug;35(4):367-379. doi: 10.1111/j.1365-2990.2008.01002.x. Epub 2008 Nov 18.
3
[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].[1号和19号染色体杂合性缺失与胶质瘤中MGMT、p53和Ki-67蛋白表达的相关性]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8.
4
Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.中国单机构 77 例间变性少突胶质细胞瘤分子预后因素及其相关性研究
Neuro Oncol. 2012 Jan;14(1):109-16. doi: 10.1093/neuonc/nor185. Epub 2011 Oct 27.
5
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
6
Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas.对低级别胶质瘤患者 O6-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)启动子甲基化的定量分析。
J Neurooncol. 2011 Jun;103(2):343-51. doi: 10.1007/s11060-010-0395-2. Epub 2010 Sep 21.
7
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.少突胶质细胞瘤和低级别弥漫性星形细胞瘤的表型与基因型相关性
Acta Neuropathol. 2002 Mar;103(3):267-75. doi: 10.1007/s004010100464. Epub 2001 Nov 22.
8
Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?多次手术的少突胶质细胞瘤中的染色体改变:肿瘤进展与1p/19q状态的变化有关吗?
J Neurooncol. 2008 Aug;89(1):37-45. doi: 10.1007/s11060-008-9597-2. Epub 2008 May 6.
9
Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors.预测少突胶质细胞瘤中1p/19q杂合性缺失的临床、组织学和免疫组化特征
Acta Neuropathol. 2005 Jul;110(1):27-38. doi: 10.1007/s00401-005-1020-x. Epub 2005 May 26.
10
Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.世界卫生组织二级胶质瘤中氟-18标记的氟脱氧葡萄糖摄取与1p和19q杂合性缺失之间的关联。
J Neurosurg. 2007 Apr;106(4):633-7. doi: 10.3171/jns.2007.106.4.633.

引用本文的文献

1
Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.原发性神经胶质瘤和配对复发肿瘤在 IDH1、TP53 和 TERTp 突变以及 MGMT、ATRX 缺失方面具有相似的生物学特征。
Sci Rep. 2017 Oct 12;7(1):13038. doi: 10.1038/s41598-017-13272-9.

本文引用的文献

1
MGMT promoter methylation in malignant gliomas.恶性神经胶质瘤中的 MGMT 启动子甲基化。
Target Oncol. 2010 Sep;5(3):161-5. doi: 10.1007/s11523-010-0153-6. Epub 2010 Aug 20.
2
Determination of the methylation status of MGMT in different regions within glioblastoma multiforme.测定胶质母细胞瘤不同区域内 MGMT 的甲基化状态。
J Neurooncol. 2011 Apr;102(2):255-60. doi: 10.1007/s11060-010-0307-5. Epub 2010 Jul 21.
3
Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.星形细胞瘤患者中1p和19q的杂合性状态及其与p53蛋白表达和表皮生长因子受体(EGFR)扩增的相关性:来自印度的新系列研究
Cancer Genet Cytogenet. 2010 Apr 15;198(2):126-34. doi: 10.1016/j.cancergencyto.2009.12.018.
4
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.MGMT 启动子甲基化可预测胶质母细胞瘤在无辅助烷化化疗的情况下对放疗的反应和预后。
Neuro Oncol. 2010 Feb;12(2):116-21. doi: 10.1093/neuonc/nop020. Epub 2009 Dec 14.
5
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化对间变性少突胶质细胞瘤辅助PCV化疗的预后有影响,但无预测作用:欧洲癌症研究与治疗组织(EORTC)脑肿瘤组26951研究报告
J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9.
6
Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.染色体 1 和 19 的三体性预示着伴有 1p/19q 缺失的间变性少突胶质细胞瘤更早复发。
Clin Cancer Res. 2009 Oct 15;15(20):6430-7. doi: 10.1158/1078-0432.CCR-09-0867. Epub 2009 Oct 6.
7
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.异柠檬酸脱氢酶1第132位密码子突变是神经胶质瘤中一种重要的预后生物标志物。
J Clin Oncol. 2009 Sep 1;27(25):4150-4. doi: 10.1200/JCO.2009.21.9832. Epub 2009 Jul 27.
8
Current concepts in the pathology and genetics of gliomas.胶质瘤病理学与遗传学的当前概念
Indian J Cancer. 2009 Apr-Jun;46(2):108-19. doi: 10.4103/0019-509x.49148.
9
Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.具有1p/19q共缺失的胶质瘤:又称少突胶质细胞瘤。
Cancer J. 2008 Nov-Dec;14(6):352-7. doi: 10.1097/PPO.0b013e31818d8178.
10
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.多形性胶质母细胞瘤中抗O6-甲基鸟嘌呤-甲基转移酶(MGMT)免疫组化:观察者间差异及与患者生存率缺乏相关性阻碍其作为临床生物标志物的应用。
Brain Pathol. 2008 Oct;18(4):520-32. doi: 10.1111/j.1750-3639.2008.00153.x. Epub 2008 Apr 8.

弥漫性浸润性胶质瘤中组织形态学预后标志物及增殖指数与1p/19q杂合性缺失和MGMT状态的相关性

Correlation of histomorphologic prognostic markers and proliferative index with loss of heterozygosity 1p/19q and MGMT status in diffusely infiltrating gliomas.

作者信息

Deb Prabal, Mani N S, Sudumbrekar S M, Taneja Nitin, Patrikar Seema

机构信息

Associate Professor, Department of Pathology, AFMC, Pune-411040, India.

DDG, MS (P), O/o DGMS (Army), Army Headquarter, New Delhi, India.

出版信息

Med J Armed Forces India. 2013 Jul;69(3):228-36. doi: 10.1016/j.mjafi.2012.08.030. Epub 2012 Dec 1.

DOI:10.1016/j.mjafi.2012.08.030
PMID:24600115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3862471/
Abstract

BACKGROUND

Loss of heterozygosity (LOH)1p/19q, and epigenetic silencing of O(6)-methylguanine-DNAmethyltransferase (MGMT) gene, displayed promising role as predictive and prognostic markers in brain tumours. The present study correlated both with conventional histomorphologic prognostic markers and proliferative index in diffusely infiltrating gliomas (DIG).

METHODS

Tissues from 45 patients were evaluated for LOH1p/19q using polymerase chain reaction based microsatellite analysis; and for MGMT using immunohistochemistry. Results were correlated with age, histologic type, WHO grade, and proliferation index.

RESULTS

Mean MIB-1 LI showed significant correlation with tumour grade. MGMT-staining in grade II and IV tumours were 31.1% and 16.8%, respectively, while in DA and GBM it was 88.2% and 19.0%, respectively, which were statistically significant. Sixteen cases showed LOH 1p and/or 19q of which 10 (5 oligodendroglial, 3 GBM, AA, DA) had combined LOH; while three each showed 1p (all GBM) and 19q (2 DA and GBM) loss. In the MIB-1LI ≤ 5% and >5% groups LOH 1p and/or 19q was encountered in 6 and 10 cases, respectively. A significant inverse association was noted between LOH with MGMT.

CONCLUSIONS

LOH1p/19q and MGMT shows good correlation with conventional histomorphologic and proliferation markers, and should constitute part of the optimal diagnostic workup of DIG.

摘要

背景

1p/19q杂合性缺失(LOH)以及O(6)-甲基鸟嘌呤-DNA甲基转移酶(MGMT)基因的表观遗传沉默在脑肿瘤中作为预测和预后标志物显示出有前景的作用。本研究将二者与弥漫性浸润性胶质瘤(DIG)中的传统组织形态学预后标志物及增殖指数进行了相关性分析。

方法

采用基于聚合酶链反应的微卫星分析对45例患者的组织进行1p/19q LOH评估;采用免疫组织化学法评估MGMT。结果与年龄、组织学类型、世界卫生组织分级及增殖指数进行相关性分析。

结果

平均MIB-1标记指数与肿瘤分级显著相关。II级和IV级肿瘤中MGMT染色分别为31.1%和16.8%,而在间变性星形细胞瘤和胶质母细胞瘤中分别为88.2%和19.0%,差异具有统计学意义。16例显示1p和/或19q LOH,其中10例(5例少突胶质细胞瘤、3例胶质母细胞瘤、间变性星形细胞瘤、间变性少突胶质细胞瘤)存在联合LOH;3例分别显示1p缺失(均为胶质母细胞瘤)和19q缺失(2例间变性少突胶质细胞瘤和胶质母细胞瘤)。在MIB-1标记指数≤5%和>5%的组中,分别有6例和10例出现1p和/或19q LOH。LOH与MGMT之间存在显著的负相关。

结论

1p/19q LOH和MGMT与传统组织形态学及增殖标志物显示出良好的相关性,应构成DIG最佳诊断检查的一部分。